HomeNewsWorldNew coronavirus strain in the UK: Scientists’ concerns and what we know so far
Trending Topics

New coronavirus strain in the UK: Scientists’ concerns and what we know so far

The rise in new COVID strain, a mutation in the novel coronavirus, has raised concerns whether COVID-19 vaccines currently under development, will now work against the variant.

December 21, 2020 / 15:57 IST
Story continues below Advertisement

A new variant of the novel coronavirus has been identified in the United Kingdom. England’s Chief Medical Officer Chris Whitty said on December 19 that the new variant of the coronavirus, which causes COVID-19, can spread faster.

Scientists are working to confirm if the mutation leads to a higher mortality rate or cause more severe illnesses.

Story continues below Advertisement

Also Read: India suspends all flights from UK till Dec 31

Whitty said that the virus mutation was likely to be the reason behind the sudden rise in COVID-19 cases around the capital and southeast of the country. “As a result of the rapid spread of the new variant, preliminary modelling data and rapidly rising incidence rates in the South East, the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) now consider that the new strain can spread more quickly,” Whitty added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show